Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Harmonized microarray/mutation scanning analysis of TP53 mutations in undissected colorectal tumors.

Favis R, Huang J, Gerry NP, Culliford A, Paty P, Soussi T, Barany F.

Hum Mutat. 2004 Jul;24(1):63-75.

PMID:
15221790
2.

An endonuclease/ligase based mutation scanning method especially suited for analysis of neoplastic tissue.

Huang J, Kirk B, Favis R, Soussi T, Paty P, Cao W, Barany F.

Oncogene. 2002 Mar 14;21(12):1909-21.

3.

P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.

de Jong KP, Gouw AS, Peeters PM, Bulthuis M, Menkema L, Porte RJ, Slooff MJ, van Goor H, van den Berg A.

Clin Cancer Res. 2005 Jun 1;11(11):4067-73.

4.

Mutation in the TP53 gene in colorectal carcinoma detected by polymerase chain reaction.

Han ES, Moyer MP, Naylor S, Sakaguchi AY.

Genes Chromosomes Cancer. 1991 Jul;3(4):313-7.

PMID:
1958596
5.

The status of p53 in the metastatic progression of colorectal cancer.

Heide I, Thiede C, Sonntag T, de Kant E, Neubauer A, Jonas S, Peter FJ, Neuhaus P, Herrmann R, Huhn D, Rochlitz CF.

Eur J Cancer. 1997 Jul;33(8):1314-22.

PMID:
9301461
6.

p53 mutations in flat- and polypoid-type colorectal tumors detected by temperature-gradient gel electrophoresis.

Yamamura-Idei Y, Satonaka K, Fujimori T, Maeda S, Chiba T.

Dig Dis Sci. 1994 Sep;39(9):2043-8.

PMID:
8082516
7.

Limitations in molecular detection of lymph node micrometastasis from colorectal cancer.

Klebig F, Fischer C, Petri S, Gerull H, Wagener C, Tschentscher P.

Diagn Mol Pathol. 2007 Jun;16(2):91-5.

PMID:
17525678
8.

Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors.

Khanna M, Park P, Zirvi M, Cao W, Picon A, Day J, Paty P, Barany F.

Oncogene. 1999 Jan 7;18(1):27-38.

9.

High sensitivity of detection of TP53 somatic mutations by fluorescence-assisted mismatch analysis.

Tessitore A, Di Rocco ZC, Cannita K, Ricevuto E, Toniato E, Tosi M, Ficorella C, Frati L, Gulino A, Marchetti P, Martinotti S.

Genes Chromosomes Cancer. 2002 Sep;35(1):86-91.

PMID:
12203794
10.

APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.

Hsieh JS, Lin SR, Chang MY, Chen FM, Lu CY, Huang TJ, Huang YS, Huang CJ, Wang JY.

Am Surg. 2005 Apr;71(4):336-43.

PMID:
15943410
11.

Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA sequence analysis.

Wen WH, Bernstein L, Lescallett J, Beazer-Barclay Y, Sullivan-Halley J, White M, Press MF.

Cancer Res. 2000 May 15;60(10):2716-22.

12.

P53 mutations in primary and metastatic tumors and circulating tumor cells from colorectal carcinoma patients.

Khan ZA, Jonas SK, Le-Marer N, Patel H, Wharton RQ, Tarragona A, Ivison A, Allen-Mersh TG.

Clin Cancer Res. 2000 Sep;6(9):3499-504.

13.

Novel TP53 gene mutations in tumors of Russian patients with breast cancer detected using a new solid phase chemical cleavage of mismatch method and identified by sequencing.

Lambrinakos A, Yakubovskaya M, Babon JJ, Neschastnova AA, Vishnevskaya YV, Belitsky GA, D'Cunha G, Horaitis O, Cotton RG.

Hum Mutat. 2004 Feb;23(2):186-92.

PMID:
14722922
14.

Rapid and sensitive p53 alteration analysis in biopsies from lung cancer patients using a functional assay and a universal oligonucleotide array: a prospective study.

Fouquet C, Antoine M, Tisserand P, Favis R, Wislez M, Commo F, Rabbe N, Carette MF, Milleron B, Barany F, Cadranel J, Zalcman G, Soussi T.

Clin Cancer Res. 2004 May 15;10(10):3479-89. Erratum in: Clin Cancer Res. 2004 Aug 1;10(15):5295.

15.

The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.

Langerød A, Bukholm IR, Bregård A, Lønning PE, Andersen TI, Rognum TO, Meling GI, Lothe RA, Børresen-Dale AL.

Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1684-8.

16.
17.

The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment.

Russo A, Bazan V, Iacopetta B, Kerr D, Soussi T, Gebbia N; TP53-CRC Collaborative Study Group..

J Clin Oncol. 2005 Oct 20;23(30):7518-28. Review.

PMID:
16172461
18.

Oligonucleotide probe array for p53 gene alteration analysis in DNA from formalin-fixed paraffin-embedded breast cancer tissues.

Lumachi F, Marino F, Varotto S, Basso U.

Ann N Y Acad Sci. 2009 Sep;1175:89-92. doi: 10.1111/j.1749-6632.2009.04969.x.

PMID:
19796081
19.

Analysis of the TP53 gene in laser-microdissected glioblastoma vasculature.

Kulla A, Burkhardt K, Meyer-Puttlitz B, Teesalu T, Asser T, Wiestler OD, Becker AJ.

Acta Neuropathol. 2003 Apr;105(4):328-32.

PMID:
12624785
20.

Simultaneous mutations in K-ras and TP53 are indicative of poor prognosis in sporadic colorectal cancer.

González-Aguilera JJ, Oliart S, Azcoita MM, Fernández-Peralta AM.

Am J Clin Oncol. 2004 Feb;27(1):39-45.

PMID:
14758132
Items per page

Supplemental Content

Support Center